Microbot Medical Inc.

MBOT | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.38

+$0.03 (+2.22%)

Sep 22, 2026, 2:46 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+2.22%

(1D)

Rating

Updated: Sep 18, 2026

Fundamentals Average

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $62.66M

1D Range

1.29 1.38

52W Range

1.28 3.74

Valuation (TTM)

PE -5.19

PB 0.89

EV/EBITDA 0.31

Valuation (NTM)

Forward PE 15.27

Forward PEG -0.81

Price Target $4

Cash Flow

FCF Yield -29.1%

SBC Adj. FCF Yield -31.1%

SBC Impact -6.8%

Margins

Gross Margin -185.3%

Operating Margin -5348.8%

FCF Margin -5181.8%

Growth (CAGR)

Revenue 3Y | 5Y 150.0% | 100.0%

Dil EPS 3Y | 5Y 48.0% | 39.6%

FCF 3Y | 5Y -42.1% | -11.0%

Returns

ROA -22.3%

ROE -21.9%

ROIC -26.5%

Financial Health

Net Cash

$66.49M

Current Ratio 18.56

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Microbot Medical Inc. operates as a pre-clinical stage medical device company, concentrating its efforts on the research, design, and development of robotic instruments for endoluminal surgery, specif...

Sector Healthcare

Industry Medical - Devices

Employees 43

IPO Date Mar 24, 1992

Website www.microbotmedical.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 11, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

Upside

+189.86%

Buy (2)

Hold (0)

Sell (0)

Analyst Details ➞